Published September 2019
| Version v1
Journal article
Effect of Intravascular Cooling on Microvascular Obstruction (MVO) in Conscious Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: Results from the COOL AMI EU Pilot Study
Creators
- 1. Department of Cardiology, Essex Cardiothoracic Centre, Basildon & Anglia Ruskin School of Medicine, Chelmsford (United Kingdom)
- 2. University Medical Center Ljubljana, Ljubljana (Slovenia)
- 3. Department of Cardiology, Silesian Center for Heart Diseases, Medical University of Silesia, SMDZ, Zabrze (Poland)
- 4. Heart Center Balatonfüred (Hungary)
- 5. Clinical Hospital Center Zemun, Faculty of Medicine, University of Belgrade, Belgrade (Serbia)
- 6. Department of Clinical Physiology, Skane University Hospital, Lund University, Lund (Sweden)
- 7. Department of Cardiology, Skane University Hospital, Lund University, Lund (Sweden)
- 8. Department of Emergency Medicine, Medical University of Vienna, Vienna (Austria)
Description
COOL AMI EU pilot was a multi-center, randomized controlled trial to assess feasibility and safety of rapid intravascular therapeutic hypothermia (TH) in conscious patients with anterior ST-elevation myocardial infarction (STEMI) undergoing primary PCI (PPCI). We report the effect of hypothermia upon microvascular obstruction (MVO).
Additional details
Identifiers
- DOI
- 10.1016/j.carrev.2018.09.014;
- PII
- S1553838918304160;
Publishing Information
- Journal Title
- Cardiovascular Revascularization Medicine (Print)
- Journal Volume
- 20
- Journal Issue
- 9
- Journal Page Range
- p. 799-804
- ISSN
- 1553-8389
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55052366
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- COOLING; HYPOTHERMIA; MYOCARDIAL INFARCTION; PATIENTS; SAFETY
- Descriptors DEC
- BODY TEMPERATURE; CARDIOVASCULAR DISEASES; DISEASES
Optional Information
- Copyright
- Copyright (c) 2018 Published by Elsevier Inc.